Tapewire

Nasdaq · USD

SOPH

SOPHiA GENETICS SA

Export transactions ↓
Tapewire entity
5228
SEC CIK
0001840706
Parsed reports
149

Last 12 months

Inside the activity.

1 purchase rows · 150 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202609
Apr 2026056
May 2026012
Jun 2026115
Jul 2026018
Aug 2026020
Sep 202607
Oct 2026013

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 19, 2026 Filed May 20, 2026 20:02 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 608 $4.60 $2,797.71
Disclosure

SEC source: 0001840706-26-000200 · wk-form4_1779307372.xml · nonDerivative · entry 1

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 626,280

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:02 UTC
Valente ManuelaChief People Officer
SaleOrdinary Shares 380 $4.60 $1,747.43
Disclosure

SEC source: 0001840706-26-000196 · wk-form4_1779307346.xml · nonDerivative · entry 1

Valente Manuela · CIK 0002009280 · Chief People Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 214,691

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.65, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:02 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 4,486 $4.60 $20,657.58
Disclosure

SEC source: 0001840706-26-000199 · wk-form4_1779307366.xml · nonDerivative · entry 1

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,629,495

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.71, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:02 UTC
Van Well DaanChief Legal Officer
SaleOrdinary Shares 684 $4.60 $3,149.27
Disclosure

SEC source: 0001840706-26-000197 · wk-form4_1779307352.xml · nonDerivative · entry 1

Van Well Daan · CIK 0002006414 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 345,052

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:03 UTC
Muken RossPresident
SaleOrdinary Shares 761 $4.60 $3,501.06
Disclosure

SEC source: 0001840706-26-000201 · wk-form4_1779307378.xml · nonDerivative · entry 1

Muken Ross · CIK 0002005463 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 680,911

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:02 UTC
Puylaert KevinChief Sales Officer
SaleOrdinary Shares 33 $4.54 $149.90
Disclosure

SEC source: 0001840706-26-000195 · wk-form4_1779307340.xml · nonDerivative · entry 1

Puylaert Kevin · CIK 0002119354 · Chief Sales Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,164

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on May 18, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades.

Read SEC document
May 13, 2026 Filed May 14, 2026 20:01 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 4,000 $4.54 $18,168.40
Disclosure

SEC source: 0001840706-26-000186 · wk-form4_1778788910.xml · nonDerivative · entry 1

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 626,888

F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.48 to $4.65, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 12, 2026 Filed May 13, 2026 20:01 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 5,000 $4.67 $23,344.50
Disclosure

SEC source: 0001840706-26-000183 · wk-form4_1778702482.xml · nonDerivative · entry 1

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 256,388

F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.56 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 12, 2026 Filed May 13, 2026 20:01 UTC SaleOrdinary Shares 7,508 $4.67 $35,036.83
Disclosure

SEC source: 0001840706-26-000184 · wk-form4_1778702489.xml · nonDerivative · entry 1

HIBBS KATHY L · CIK 0001267487 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,768

F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 20:01 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 8,500 $5.09 $43,241.20
Disclosure

SEC source: 0001840706-26-000180 · wk-form4_1778616075.xml · nonDerivative · entry 1

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,633,981

F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.72 to $5.49, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 27, 2026 Filed Apr 28, 2026 20:03 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 5,000 $4.82 $24,089.00
Disclosure

SEC source: 0001840706-26-000176 · wk-form4_1777406606.xml · nonDerivative · entry 1

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 261,388

F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.75 to $4.89, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:04 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 608 $5.20 $3,161.72
Disclosure

SEC source: 0001840706-26-000170 · wk-form4_1776801867.xml · nonDerivative · entry 1

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 266,388

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:04 UTC
Valente ManuelaChief People Officer
SaleOrdinary Shares 380 $5.20 $1,977.18
Disclosure

SEC source: 0001840706-26-000174 · wk-form4_1776801885.xml · nonDerivative · entry 1

Valente Manuela · CIK 0002009280 · Chief People Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 215,071

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:04 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 4,486 $5.21 $23,349.63
Disclosure

SEC source: 0001840706-26-000171 · wk-form4_1776801871.xml · nonDerivative · entry 1

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,642,481

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.08 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:04 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 608 $5.21 $3,164.82
Disclosure

SEC source: 0001840706-26-000173 · wk-form4_1776801880.xml · nonDerivative · entry 1

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 630,888

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:04 UTC
Van Well DaanChief Legal Officer
SaleOrdinary Shares 684 $5.20 $3,554.27
Disclosure

SEC source: 0001840706-26-000172 · wk-form4_1776801876.xml · nonDerivative · entry 1

Van Well Daan · CIK 0002006414 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 345,736

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:04 UTC
Muken RossPresident
SaleOrdinary Shares 760 $5.20 $3,954.96
Disclosure

SEC source: 0001840706-26-000169 · wk-form4_1776801861.xml · nonDerivative · entry 1

Muken Ross · CIK 0002005463 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 681,672

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:04 UTC
Puylaert KevinChief Sales Officer
SaleOrdinary Shares 33 $5.08 $167.69
Disclosure

SEC source: 0001840706-26-000168 · wk-form4_1776801856.xml · nonDerivative · entry 1

Puylaert Kevin · CIK 0002119354 · Chief Sales Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,197

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on April 18, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades.

Read SEC document
April 15, 2026 Filed Apr 16, 2026 20:03 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 17,473 $5.00 $87,401.69
Disclosure

SEC source: 0001840706-26-000159 · wk-form4_1776369811.xml · nonDerivative · entry 2

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,646,967

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.90 to $5.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 14, 2026 Filed Apr 16, 2026 20:03 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 1,600 $4.96 $7,932.96
Disclosure

SEC source: 0001840706-26-000158 · wk-form4_1776369806.xml · nonDerivative · entry 1

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 266,996

F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $5.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 14, 2026 Filed Apr 16, 2026 20:03 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 43,129 $4.96 $213,833.58
Disclosure

SEC source: 0001840706-26-000159 · wk-form4_1776369811.xml · nonDerivative · entry 1

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,664,440

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.73 to $5.18, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 14, 2026 Filed Apr 16, 2026 20:03 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 600 $4.97 $2,979.78
Disclosure

SEC source: 0001840706-26-000160 · wk-form4_1776369817.xml · nonDerivative · entry 1

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 631,496

F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.82 to $5.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 14, 2026 Filed Apr 16, 2026 20:03 UTC
Muken RossPresident
SaleOrdinary Shares 2,800 $4.96 $13,887.16
Disclosure

SEC source: 0001840706-26-000157 · wk-form4_1776369800.xml · nonDerivative · entry 1

Muken Ross · CIK 0002005463 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 682,432

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.75 to $5.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 13, 2026 Filed Apr 14, 2026 20:01 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 3,400 $4.76 $16,198.28
Disclosure

SEC source: 0001840706-26-000148 · wk-form4_1776196912.xml · nonDerivative · entry 3

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,596

F4 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.62 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 13, 2026 Filed Apr 14, 2026 20:01 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 1,000 $4.76 $4,764.20
Disclosure

SEC source: 0001840706-26-000148 · wk-form4_1776196912.xml · nonDerivative · entry 2

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 271,996

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.62 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 13, 2026 Filed Apr 14, 2026 20:02 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 4,399 $4.76 $20,957.28
Disclosure

SEC source: 0001840706-26-000150 · wk-form4_1776196923.xml · nonDerivative · entry 3

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,707,569

F3 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.64 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 13, 2026 Filed Apr 14, 2026 20:02 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 3,400 $4.76 $16,196.58
Disclosure

SEC source: 0001840706-26-000151 · wk-form4_1776196927.xml · nonDerivative · entry 3

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 632,096

F4 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 13, 2026 Filed Apr 14, 2026 20:02 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 1,014 $4.76 $4,830.39
Disclosure

SEC source: 0001840706-26-000151 · wk-form4_1776196927.xml · nonDerivative · entry 2

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 635,496

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 13, 2026 Filed Apr 14, 2026 20:02 UTC
Muken RossPresident
SaleOrdinary Shares 4,442 $4.77 $21,166.13
Disclosure

SEC source: 0001840706-26-000149 · wk-form4_1776196918.xml · nonDerivative · entry 2

Muken Ross · CIK 0002005463 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 685,232

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 (c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.62 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 20:01 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 3,725 $4.68 $17,441.20
Disclosure

SEC source: 0001840706-26-000148 · wk-form4_1776196912.xml · nonDerivative · entry 1

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 272,996

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 20:02 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 3,732 $4.72 $17,607.58
Disclosure

SEC source: 0001840706-26-000150 · wk-form4_1776196923.xml · nonDerivative · entry 2

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,711,968

F3 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.60 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 20:02 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 8,500 $4.72 $40,103.00
Disclosure

SEC source: 0001840706-26-000150 · wk-form4_1776196923.xml · nonDerivative · entry 1

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,715,700

F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.60 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 20:02 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 3,706 $4.68 $17,347.04
Disclosure

SEC source: 0001840706-26-000151 · wk-form4_1776196927.xml · nonDerivative · entry 1

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 636,510

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 20:02 UTC
Van Well DaanChief Legal Officer
SaleOrdinary Shares 2,400 $4.67 $11,201.28
Disclosure

SEC source: 0001840706-26-000152 · wk-form4_1776196932.xml · nonDerivative · entry 1

Van Well Daan · CIK 0002006414 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 346,420

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 10, 2026 Filed Apr 14, 2026 20:02 UTC
Muken RossPresident
SaleOrdinary Shares 3,687 $4.69 $17,278.76
Disclosure

SEC source: 0001840706-26-000149 · wk-form4_1776196918.xml · nonDerivative · entry 1

Muken Ross · CIK 0002005463 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 689,674

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 (c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:02 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 1,931 $4.74 $9,151.59
Disclosure

SEC source: 0001840706-26-000139 · wk-form4_1775851351.xml · nonDerivative · entry 2

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 276,721

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.655 to $4.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:02 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 1,936 $4.74 $9,176.45
Disclosure

SEC source: 0001840706-26-000140 · wk-form4_1775851359.xml · nonDerivative · entry 2

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 640,216

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:02 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 1,950 $4.74 $9,243.78
Disclosure

SEC source: 0001840706-26-000142 · wk-form4_1775851376.xml · nonDerivative · entry 2

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,724,200

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.665 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:02 UTC
Van Well DaanChief Legal Officer
SaleOrdinary Shares 1,988 $4.74 $9,424.31
Disclosure

SEC source: 0001840706-26-000137 · wk-form4_1775851332.xml · nonDerivative · entry 2

Van Well Daan · CIK 0002006414 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 348,820

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · balance_after: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:02 UTC
Muken RossPresident
SaleOrdinary Shares 1,950 $4.74 $9,238.91
Disclosure

SEC source: 0001840706-26-000141 · wk-form4_1775851367.xml · nonDerivative · entry 2

Muken Ross · CIK 0002005463 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 693,361

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.665 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 2,800 $4.84 $13,543.60
Disclosure

SEC source: 0001840706-26-000139 · wk-form4_1775851351.xml · nonDerivative · entry 1

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 278,652

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
Valente ManuelaChief People Officer
SaleOrdinary Shares 3,824 $4.85 $18,542.58
Disclosure

SEC source: 0001840706-26-000138 · wk-form4_1775851340.xml · nonDerivative · entry 1

Valente Manuela · CIK 0002009280 · Chief People Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 215,451

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
Xu ZhenyuChief Scientific Officer
SaleOrdinary Shares 2,800 $4.84 $13,549.20
Disclosure

SEC source: 0001840706-26-000140 · wk-form4_1775851359.xml · nonDerivative · entry 1

Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 642,152

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: prices ranging from $4.79 to $4.92, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 2,800 $4.84 $13,553.12
Disclosure

SEC source: 0001840706-26-000142 · wk-form4_1775851376.xml · nonDerivative · entry 1

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,726,150

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
Van Well DaanChief Legal Officer
SaleOrdinary Shares 2,861 $4.85 $13,862.12
Disclosure

SEC source: 0001840706-26-000137 · wk-form4_1775851332.xml · nonDerivative · entry 1

Van Well Daan · CIK 0002006414 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 350,808

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
Muken RossPresident
SaleOrdinary Shares 2,786 $4.84 $13,488.14
Disclosure

SEC source: 0001840706-26-000141 · wk-form4_1775851367.xml · nonDerivative · entry 1

Muken Ross · CIK 0002005463 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 695,311

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.77 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
CARDOZA GEORGEChief Financial Officer
SaleOrdinary Shares 1,403 $4.85 $6,800.62
Disclosure

SEC source: 0001840706-26-000136 · wk-form4_1775851324.xml · nonDerivative · entry 1

CARDOZA GEORGE · CIK 0001518734 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 291,458

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.79 to $4.93, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 07, 2026 Filed Apr 8, 2026 20:05 UTC
Menu PhilippeChief Medical Officer
SaleOrdinary Shares 2,400 $4.87 $11,676.72
Disclosure

SEC source: 0001840706-26-000128 · wk-form4_1775678710.xml · nonDerivative · entry 2

Menu Philippe · CIK 0002014308 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 281,452

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · balance_after: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 07, 2026 Filed Apr 8, 2026 20:04 UTC
Camblong JurgiDirector · Chief Executive Officer
SaleOrdinary Shares 2,500 $4.86 $12,154.75
Disclosure

SEC source: 0001840706-26-000124 · wk-form4_1775678672.xml · nonDerivative · entry 2

Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,728,950

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.69 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 07, 2026 Filed Apr 8, 2026 20:04 UTC
Valente ManuelaChief People Officer
SaleOrdinary Shares 2,376 $4.87 $11,565.89
Disclosure

SEC source: 0001840706-26-000122 · wk-form4_1775678653.xml · nonDerivative · entry 2

Valente Manuela · CIK 0002009280 · Chief People Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 219,275

F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.68 to $5.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.